Early Comparison of Major Bleeding, Stroke and Associated Medical Costs Among Treatment-Naive Non-Valvular Atrial Fibrillation Patients Initiating Apixaban, Dabigatran, Rivaroxaban or Warfarin
No Thumbnail Available
Date
2015
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Open Access Color
OpenAIRE Downloads
OpenAIRE Views
Abstract
...
Description
Onur Başer (MEF Author)
##nofulltext##
##nofulltext##
Keywords
Turkish CoHE Thesis Center URL
Fields of Science
Citation
Alpesh AN, Keshishian A, Xie L, Baser O, Price K, Vo L, Singh P, Bruno A, Mardekian J, Tan W, Singhal S, Patel C, Odell K, Trocio J. ( December 5-8, 2015). Early comparison of major bleeding, stroke and associated medical costs among treatment-naive non-valvular atrial fibrillation patients initiating apixaban, dabigatran, rivaroxaban or warfarin. American Society of Hematology (ASH) Annual Meeting and Exposition. Orlando. [oral presentation]
WoS Q
Scopus Q
Source
American Society of Hematology (ASH) Annual Meeting and Exposition
Volume
Issue
Start Page
End Page
Collections
Google Scholar™
Sustainable Development Goals
4
QUALITY EDUCATION
11
SUSTAINABLE CITIES AND COMMUNITIES
12
RESPONSIBLE CONSUMPTION AND PRODUCTION
13
CLIMATE ACTION
14
LIFE BELOW WATER
16
PEACE, JUSTICE AND STRONG INSTITUTIONS
